222 related articles for article (PubMed ID: 22542170)
41. Study of loss of heterozygosity at DCC and APC/MCC genetic loci of gastric cancer.
Wang D; Fang D; Luo Y; Lu R; Liu W
Chin Med Sci J; 1999 Jun; 14(2):107-11. PubMed ID: 12901620
[TBL] [Abstract][Full Text] [Related]
42. Promoter methylation of the TSLC1 gene in advanced lung tumors and various cancer cell lines.
Fukami T; Fukuhara H; Kuramochi M; Maruyama T; Isogai K; Sakamoto M; Takamoto S; Murakami Y
Int J Cancer; 2003 Oct; 107(1):53-9. PubMed ID: 12925956
[TBL] [Abstract][Full Text] [Related]
43. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
44. Epithelial membrane protein 3 is frequently shown as promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Xue Q; Zhou Y; Wan C; Lv L; Chen B; Cao X; Ju G; Huang Y; Ni R; Mao G
Exp Mol Pathol; 2013 Dec; 95(3):313-8. PubMed ID: 23920144
[TBL] [Abstract][Full Text] [Related]
45. Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer.
Kohonen-Corish MR; Sigglekow ND; Susanto J; Chapuis PH; Bokey EL; Dent OF; Chan C; Lin BP; Seng TJ; Laird PW; Young J; Leggett BA; Jass JR; Sutherland RL
Oncogene; 2007 Jun; 26(30):4435-41. PubMed ID: 17260021
[TBL] [Abstract][Full Text] [Related]
46. RARβ Promoter Methylation as an Epigenetic Mechanism of Gene Silencing in Non-small Cell Lung Cancer.
Dutkowska A; Antczak A; Pastuszak-Lewandoska D; Migdalska-Sek M; Czarnecka KH; Górski P; Kordiak J; Nawrot E; Brzeziańska-Lasota E
Adv Exp Med Biol; 2016; 878():29-38. PubMed ID: 26453065
[TBL] [Abstract][Full Text] [Related]
47. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer.
Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L
Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809
[TBL] [Abstract][Full Text] [Related]
48. Loss of heterozygosity of APC and MCC genes in oral squamous cell carcinomas in Taiwan.
Huang JS; Chiang CP; Kok SH; Kuo YS; Kuo MY
J Oral Pathol Med; 1997 Aug; 26(7):322-6. PubMed ID: 9250932
[TBL] [Abstract][Full Text] [Related]
49. APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q.
Arnold CN; Goel A; Niedzwiecki D; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
Cancer Biol Ther; 2004 Oct; 3(10):960-4. PubMed ID: 15326380
[TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity at APC and MCC genes of oral cancer and leukoplakia tissues from Indian tobacco chewers.
Sikdar N; Paul RR; Panda CK; Banerjee SK; Roy B
J Oral Pathol Med; 2003 Sep; 32(8):450-4. PubMed ID: 12901725
[TBL] [Abstract][Full Text] [Related]
51. FHIT promoter methylation status, low protein and high mRNA levels in patients with non-small cell lung cancer.
Czarnecka KH; Migdalska-Sęk M; Domańska D; Pastuszak-Lewandoska D; Dutkowska A; Kordiak J; Nawrot E; Kiszałkiewicz J; Antczak A; Brzeziańska-Lasota E
Int J Oncol; 2016 Sep; 49(3):1175-84. PubMed ID: 27572663
[TBL] [Abstract][Full Text] [Related]
52. The property of methylated APC gene promotor and its influence on lung cancer cell line.
Pan S; Zhang L; Gao L; Gu B; Wang F; Xu J; Shu Y; Yang D; Chen Z
Biomed Pharmacother; 2009 Aug; 63(7):463-8. PubMed ID: 18996677
[TBL] [Abstract][Full Text] [Related]
53. Promoter methylation of Wnt antagonist DKK1 gene and prognostic value in Korean patients with non-small cell lung cancers.
Na Y; Lee SM; Kim DS; Park JY
Cancer Biomark; 2012; 12(2):73-9. PubMed ID: 23396252
[TBL] [Abstract][Full Text] [Related]
54. Methylation of the DCLK1 promoter region in circulating free DNA and its prognostic value in lung cancer patients.
Powrózek T; Krawczyk P; Nicoś M; Kuźnar-Kamińska B; Batura-Gabryel H; Milanowski J
Clin Transl Oncol; 2016 Apr; 18(4):398-404. PubMed ID: 26311076
[TBL] [Abstract][Full Text] [Related]
55. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line.
Sato N; Fukui T; Taniguchi T; Yokoyama T; Kondo M; Nagasaka T; Goto Y; Gao W; Ueda Y; Yokoi K; Minna JD; Osada H; Kondo Y; Sekido Y
Int J Cancer; 2007 Feb; 120(3):543-51. PubMed ID: 17096327
[TBL] [Abstract][Full Text] [Related]
56. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas.
Virmani AK; Rathi A; Zöchbauer-Müller S; Sacchi N; Fukuyama Y; Bryant D; Maitra A; Heda S; Fong KM; Thunnissen F; Minna JD; Gazdar AF
J Natl Cancer Inst; 2000 Aug; 92(16):1303-7. PubMed ID: 10944551
[TBL] [Abstract][Full Text] [Related]
57. Loss of TIMP-3 promotes tumor invasion via elevated IL-6 production and predicts poor survival and relapse in HPV-infected non-small cell lung cancer.
Wu DW; Tsai LH; Chen PM; Lee MC; Wang L; Chen CY; Cheng YW; Lee H
Am J Pathol; 2012 Nov; 181(5):1796-806. PubMed ID: 22982189
[TBL] [Abstract][Full Text] [Related]
58. PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration.
Marsit CJ; Zheng S; Aldape K; Hinds PW; Nelson HH; Wiencke JK; Kelsey KT
Hum Pathol; 2005 Jul; 36(7):768-76. PubMed ID: 16084946
[TBL] [Abstract][Full Text] [Related]
59. Promoter hypermethylation of the CFTR gene and clinical/pathological features associated with non-small cell lung cancer.
Son JW; Kim YJ; Cho HM; Lee SY; Lee SM; Kang JK; Lee JU; Lee YM; Kwon SJ; Choi E; Na MJ; Park JY; Kim DS
Respirology; 2011 Nov; 16(8):1203-9. PubMed ID: 21585618
[TBL] [Abstract][Full Text] [Related]
60. Does adenomatous polyposis coli gene promoter 1A methylation increase non-small cell lung cancer risk? A meta-analysis.
Hu B; Zhang H; Wei H; Wang Z; Zhang F; Wang X; Li L
Thorac Cancer; 2017 Sep; 8(5):410-416. PubMed ID: 28497891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]